For mid‑size hospital laboratories, an automatic hematology analyzer has become the central engine of routine CBC testing and clinical decision‑making. As patient volumes grow and technologist resources remain tight, labs must shift from manual microscopy and basic impedance systems to AI‑driven automation that delivers faster, more standardized results.

This article explains how modern automatic hematology analyzers work, how AI‑powered systems such as Ozelle’s EHBT‑75 change daily workflow in hospital labs, and what to consider when planning an upgrade.

What is an automatic hematology analyzer?

An automatic hematology analyzer is an instrument that processes a small blood sample and generates a complete blood count with white cell differential, red cell indices, and platelet parameters without manual counting. It replaces repetitive microscope work with automated sample processing, measurement, and data analysis, so technologists can focus on reviewing complex or flagged cases rather than every slide.ozellemed

Modern analyzers typically combine several measurement principles in one compact device. They perform multi‑parameter counting, identify abnormal distributions, and apply decision rules to generate a structured report that integrates numeric values, reference ranges, and system flags. In devices like Ozelle’s EHBT‑75, this automated framework is extended further with image‑based analysis and artificial intelligence.

From manual microscopy to AI‑powered CBM

Limitations of traditional workflows

In many hospitals, CBC testing has historically relied on a hybrid of basic analyzers and manual smear review. The analyzer provides counts and simple differentials, while technologists stain and interpret blood smears when the instrument flags a result or clinicians request morphology. This model is time‑consuming, heavily dependent on individual expertise, and difficult to standardize across shifts.

As volumes rise, manual microscopy quickly becomes a bottleneck. Turnaround times stretch, technologists face repetitive workloads, and there is a constant risk of variation in how subtle abnormalities are interpreted. These pressures are exactly what AI‑enabled analyzers aim to relieve.

How AI Complete Blood Morphology works

Ozelle’s automatic analyzers use a Complete Blood Morphology (CBM) approach that integrates high‑resolution imaging with deep learning models. Cells are captured by a SwissOptic lens at multi‑megapixel resolution and high frame rates, then processed through convolutional neural networks trained on more than 40 million clinical samples.

This allows the analyzer to recognize detailed white cell subsets, abnormal neutrophil forms, reticulocytes, immature cells, and platelet aggregates directly from images. Rather than sending most flagged samples to manual microscopy, the instrument itself produces morphology‑aware flags and representative cell images, which technologists can review on screen or through integrated software.

Key benefits in a hospital laboratory

Faster and more consistent turnaround

By integrating CBC, differential, and morphology into a single automated run, AI‑enabled analyzers shorten the path from sample receipt to verified result. Ozelle reports that EHBT‑75 can complete a full 7‑part differential CBC in roughly six minutes per sample, including morphology analysis and abnormal cell flags. In practical terms, this allows emergency and inpatient teams to receive results within the same round of clinical decision‑making, rather than waiting for additional smear work.

Because interpretation is algorithm‑driven, this speed does not rely on a particular technologist being on duty. The system applies the same analytical rules throughout the day and night, which stabilizes performance across shifts and reduces the variability that often appears with manual smear review.

Higher diagnostic depth from a single sample

Traditional impedance analyzers excel at counting but are limited in how they describe cell morphology. AI CBM systems add more informative parameters without requiring a separate test. Ozelle’s EHBT‑75, for example, reports more than thirty‑seven parameters, including advanced white cell subsets such as band neutrophils, hypersegmented neutrophils, atypical lymphocytes, reticulocyte counts, and platelet morphology indices.

This additional detail enriches reports for conditions where subtle shifts in cell population matter. Clinicians managing sepsis, hematologic malignancy, severe anemia, or autoimmune disease can see not only counts and indices but also how cell types and maturity patterns change over time.

EHBT‑75 as an automatic hematology analyzer example

Core technical profile

Ozelle positions the EHBT‑75 as a dedicated 7‑diff automatic hematology analyzer for professional labs that require high diagnostic value in a relatively small footprint. The system combines CBC counting with image‑based morphology and AI interpretation.

According to Ozelle’s technical information, EHBT‑75 supports whole‑blood and capillary samples with low volume requirements, uses a single‑use cartridge system for reagents and waste, and maintains room‑temperature storage for consumables. This design helps minimize maintenance tasks, reduces downtime due to clogs or reagent issues, and simplifies daily operation for laboratory staff.

Integration in a wider product family

EHBT‑75 sits within a broader hematology portfolio that also includes EHBT‑25, a 3‑diff CBC analyzer intended for primary care and small labs, and EHBT‑50, a multi‑functional “mini lab” that combines CBC with immunoassay and dry chemistry in a single device. Hospital networks can align different sites and departments on the same CBM and AI technology while choosing devices that match each location’s workload and clinical scope.EHBT-25-Introduction_250411.pdf+1ozellemed

For more details on EHBT‑75 within Ozelle’s hematology range, see the official page: https://ozellemed.com/en/ehbt-75/ozellemed

Comparing AI CBM analyzers with traditional methods

Manual microscopy versus automation

Manual microscopy still offers unmatched flexibility for rare or complex cases but struggles to keep pace with routine demand. Each smear requires careful staining, inspection, and documentation, which limits throughput and makes performance heavily dependent on individual experience. AI CBM analyzers aim to preserve the useful parts of morphology while removing the bottlenecks.

In an automated workflow, the analyzer performs the initial classification and produces a combined numeric and image‑based report. Technologists then focus their attention on cases the system flags as abnormal or uncertain, reviewing the images and deciding whether additional manual work is needed. This reallocation of effort leads to faster routine processing and a more targeted use of expert time.

Impedance‑only analyzers versus AI‑enabled systems

Impedance‑only analyzers measure cell size and volume changes as cells pass through an aperture, which works well for basic counts but offers limited morphological insight. They are fast but often rely on fixed rule‑based flags that may not capture subtle or unusual patterns.

AI‑enabled systems like Ozelle’s EHBT‑75 extend beyond volume‑based detection. By using real images as input, they can learn complex visual features associated with specific abnormal forms, even when counts or volumes fall within broadly normal ranges. In everyday lab practice, this improves early recognition of abnormal populations and reduces the risk that atypical cells remain hidden behind apparently acceptable numeric values.

Role of automatic hematology analyzers in a diagnostic ecosystem

Central lab and satellite collaboration

In a modern hospital, CBC testing is rarely confined to a single room. Central labs, emergency departments, outpatient centers, and satellite clinics may all need hematology results at different speeds and volumes. Ozelle’s ecosystem approach uses different analyzers at different levels while keeping them connected through shared data platforms.

Central labs might deploy devices like EHBT‑75 for full 7‑diff CBC with morphology, while smaller units use EHBT‑25 for rapid 3‑diff screening and send complex cases to the core laboratory. Because these analyzers share similar interfaces and technology foundations, training and quality assurance are easier to manage.

Connectivity, data and quality control

Connectivity is another core requirement for automatic analyzers. Ozelle integrates its hematology devices with LIS and hospital systems, and offers an IoT‑based management platform for multi‑site monitoring. This allows laboratory leaders to track device status, consumable usage, QC performance, and test volumes in real time across a network of instruments.

From a quality perspective, standardized QC procedures, dry‑type QC cards, and centralized reporting help maintain consistent performance. This combination of hardware, software, and data infrastructure turns the analyzer from a standalone machine into part of a broader digital diagnostic environment.

Planning an upgrade to an automatic hematology analyzer

Assessing clinical and operational needs

When a mid‑size hospital lab considers upgrading its hematology platform, the first step is to clarify which clinical services the analyzer must support. Oncology, hematology, intensive care, and emergency medicine all place high demands on CBC and differential performance, especially for morphology and flagging. Understanding how these departments use CBC reports helps determine whether a 3‑part or 7‑part differential is appropriate and how much weight to place on advanced parameters.

Operational considerations matter just as much. Labs should examine total daily CBC volume, peak times, staffing patterns, and existing infrastructure for sample preparation and data integration. In many mid‑size hospitals, the optimal solution is a compact, high‑value analyzer like EHBT‑75 that offers advanced capabilities without the footprint or complexity of very high‑throughput core‑lab systems.

Financial and maintenance considerations

Budget planning for an automatic analyzer must go beyond purchase price. Consumables, service, downtime risk, and staffing all contribute to the long‑term cost of ownership. Cartridge‑based, maintenance‑free designs reduce the need for engineering interventions, minimize unplanned downtime and simplify routine checks, which is particularly important for laboratories operating around the clock.

AI‑enabled analyzers also influence cost indirectly. By reducing manual smear workload and shortening turnaround times, they can increase laboratory throughput, improve clinician satisfaction, and support better patient flow in high‑acuity departments. These operational gains are harder to quantify but often play a decisive role when evaluating return on investment.

Where to learn more

Ozelle provides detailed information on its AI‑powered hematology analyzers, including EHBT‑75 and the broader CBM technology, on its official site. A good starting point is the hematology analyzer overview page, which explains the product families, core technologies, and supported scenarios: https://ozellemed.com/en/hematology/ozellemed

You can then explore the EHBT‑75 dedicated page for technical specifications and clinical positioning in more depth: https://ozellemed.com/en/ehbt-75/ozellemed